ClinicalTrials.gg
CompletedNCT03366831Updated May 10, 2023

Newborn Implementation

An interventional study of Thirty Million Words Initiative Newborn Intervention in Language Development, sponsored by University of Chicago. Completed at 3 sites in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by University of Chicago · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Apr 2017, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
2,701
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of the proposed research is to perform testing of the Thirty Million Words Newborn Initiative (TMW-NI) with the primary goal of evaluating various implementation methods.

The investigators hypothesize that the TMW-Newborn intervention will:

  1. Significantly impact parent knowledge regarding the importance of universal newborn hearing screen (UNHS) follow-up
  2. Significantly impact parent knowledge of child development

    Additionally,the investigators hypothesize that:

  3. The 7-minute version of the video with questions interspersed will most significantly improve parent knowledge of child development
  4. There will be no significant differences in effectiveness of the Spanish and English versions of the TMW-Newborn intervention

The hypotheses rely on the existing research data supporting the idea that parental understanding and beliefs will alter parental behavior, and consequently, that increased parental linguistic input will impact child cognitive development.

Read the detailed description

The investigators propose to perform a randomized implementation trial to evaluate the efficacy of various implementation methods of the TMW-Newborn educational intervention. The study will be conducted in temporal proximity to the administration of the universal newborn hearing screen.

After routine delivery, postpartum mothers are admitted to the mother-baby unit for 48-72 hours. A hearing screening technician of the Sacred Heart Hospital will deliver the tablet that houses the intervention to every mother whose child is receiving the hearing screening. The technician will give each mother a tablet set up to the HIPAA Compliant TMW-Newborn Web Platform that houses the randomization tool, the welcome video, the tablet based consent passage, the surveys, and the educational intervention videos. First, the participant will watch the welcome video and complete the tablet based consent. Then, the participant will be randomized into one of four conditions: 15 minute version of the TMW-Newborn intervention video without questions interspersed, the 15 minute version of the TMW-Newborn intervention video with questions interspersed, the 7 minute version of the TMW-Newborn intervention video without questions interspersed, or the 7 minute version of the TMW-Newborn intervention video with questions interspersed.

After randomization, the participant will be brought to the screen with the SPEAK III to complete. Then, they will answer a few non-identifying demographics questions. These surveys takes approximately 10 minutes to complete will be followed by either a 15-minute or 7-minute video.

After watching their assigned video, all participants will repeat the SPEAK questionnaire for a second time. Then, the hearing screener will pick up the tablet from the participant. No identifying information is being collected within the TMW-Newborn web platform, and the hearing screening technicians will not be able to see or access any of the participants' responses.

After all surveys are complete, the hearing screening technician will pick up the tablet from the participant and answer any remaining questions.

This study protocol will only be used at Sacred Heart Hospital, Baptist Hospital, and University of Chicago Hospital.

02

Conditions studied

  • Language Development

Browse trials for

03

In context

Language

243 studies on the registry are indexed under Language; 76 are open to participants now.

This study's enrollment of 2,701 is above the median of 65 across 158 interventional studies indexed under Language.

Browse Language studies →

Lead sponsor

University of Chicago is the lead sponsor of 924 studies on the registry; 185 are open to participants now.

Of its 103 completed or terminated interventional studies of FDA-regulated products, 72 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

New mothers at Sacred Heart Hospital, University of Chicago Medical Center, and Baptist Hospital-Pensacola.

Exclusion criteria

Exclusion Criteria:

Individuals that do not have a live birth at Sacred Heart Hospital, University of Chicago Medical Center, or Baptist Hospital-Pensacola or do not receive the UNHS at one of these locations will not be eligible for this study.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
2,701 participants (actual)

Study arms

  • Active comparator
    15 minute version without questions

    15 minute version of the TMW-Newborn intervention video without questions interspersed

    Behavioral: Thirty Million Words Initiative Newborn Intervention

  • Active comparator
    15 minute version with questions

    15 minute version of the TMW-Newborn intervention video with questions interspersed

    Behavioral: Thirty Million Words Initiative Newborn Intervention

  • Active comparator
    7 minute version without questions

    7 minute version of the TMW-Newborn intervention video without questions interspersed

    Behavioral: Thirty Million Words Initiative Newborn Intervention

  • Active comparator
    7 minute version with questions

    7 minute version of the TMW-Newborn intervention video with questions interspersed.

    Behavioral: Thirty Million Words Initiative Newborn Intervention

Interventions

  • BehavioralThirty Million Words Initiative Newborn Intervention

    The Thirty Million Words Initiative Newborn Intervention (TMW-Newborn) is a public health effort aimed at increasing awareness about the importance of a child's early language environment in his or her first years of life. This one-time educational intervention will be impacting maternal awareness and knowledge about the importance of children's early language environment, between ages 0 and 3.

06

What researchers measure

Primary outcomes

  1. SPEAK Survey (Baby Subscales)

    measures an individuals expectations and knowledge about child development

    Time frame: 48-72 after routine delivery

07

Study locations

3 sites
  • Sacred Heart Hospital
    Pensacola, Florida 19141, United States
  • Baptist Hospital
    Pensacola, Florida 32501, United States
  • TMW Center for Early Learning + Public Health at the University of Chicago Medicine
    Chicago, Illinois 60637, United States
08

References and documents

Publications

  • Suskind DL, Leung CYY, Webber RJ, Hundertmark AC, Leffel KR, Fuenmayor Rivas IE, Grobman WA. Educating Parents About Infant Language Development: A Randomized Controlled Trial. Clin Pediatr (Phila). 2018 Jul;57(8):945-953. doi: 10.1177/0009922817737079. Epub 2017 Oct 26. PubMed 29073768 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — IPD will not be shared

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2017 to primary completion in Nov 2019, 30 months.

Of 89 non-industry interventional studies with no phase under Language, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 64. This study's 30 months is close to that.

Counting every sponsor, half of 93 studies reached it within 33 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2017
First posted
Dec 8, 2017
StartActual
Apr 10, 2017
Primary completionActual
Nov 6, 2019
CompletionActual
Nov 6, 2019
Last update
May 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03366831
Responsible party
Sponsor
First posted
Dec 8, 2017
Start date
Apr 10, 2017
Primary completion
Nov 6, 2019
Completion
Nov 6, 2019
Last update
May 10, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion